Doreen Osgood-Dean

  • Clinical Assistant Professor
  • Phone: 401.277.5219
  • Email:
  • Office Location: Woodward Hall, Rm 239


Doreen Osgood-Dean is the director of the Amgen Biotech Experience RI site program. This grant is a global innovative science education program that introduces high school students to the excitement of scientific discovery and builds bridges between school and the real-life biosciences. In addition, Dr. Osgood-Dean is a faculty member in the Biotechnology program and manages the Biotechnology lab courses. Prior to joining URI, she was the senior analytical scientist at Molecular MS Diagnostics and a research scientist in Neurosurgery Research, Rhode Island Hospital.


  • Ph.D., Tufts University, 2000
  • M.S., University of Rhode Island, 1990
  • B.S., Providence College, 1987

Selected Publications

Osgood D, Miller MC, Messier AA, Gonzalez L, Silverberg GD. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier. Neurobiol Aging, 2017 May 19;57:178-185.

Chiu C, Miller MC, Monahan R, Osgood DP, Stopa EG, Silverberg G . P- glycoprotein expression and amyloid accumulation in human aging and AD: preliminary observations. Neurobiol Aging. 2015 Sep;36(9):2475-82.

Church RM, Miller MC, Freestone D,Chiu C, Osgood DP, Machan JT, Messier AM, Johhanson CE, Silverberg G. Amyloid-beta Accumulation, Neurogenesis, Behavior, and Aging of Rats. Behavioral Neuroscience, Vol 128(4), Aug 2014, 523-536

Osgood DP, Harrington WF, Kenney EV, Harrington JF. The utility of ionotropic glutamate receptor antagonists in the treatment of nociception induced by epidural glutamate infusionin. Surg Neurol Int 2013;4:106.